The Perelman School of Medicine’s Dominic Sisti co-authored a paper on the possible hazards of using ketamine to treat depression but has since come to view the treatment as appropriate for some. Still, Sisti believes it would be beneficial for clinics to share more data on outcomes.

April 4, 2018 ・ From Chicago Tribune